UK Researchers ask: what if we approached dementia research the same way we approach cancer?

Pete Comparoni/Pete Comparoni

In the ever-evolving field of Alzheimer’s disease research, the development of disease-modifying therapies has sparked both excitement and debate. Two new publications from University of Kentucky researchers highlight critical advancements and their intersection with other fields that are considered more successful in advances to date. The collaborative papers were led by Greg Jicha, M.D., Ph.D., and Pete Nelson, M.D., Ph.D., both with UK’s Sanders-Brown Center on Aging. The work showcases the profound impact of partnerships across UK — in this case between the Alzheimer’s Disease Research Center and the UK Markey Cancer Center. Dr. Greg talks with Nelson about this team approach to tackling this vexing disease.